TRITE > Topics

Your browser does not support JavaScript or JavaScript has been disabled. Please upgrade to a newer version of the browser or enable JavaScript. You might still be able to use some of the features but some of the useful features use JavaScript. Thank you!

ARGH Biomedical Acronym Resolver

Your browser does not support JavaScript or JavaScript has been disabled. Please upgrade to a newer version of the browser or enable JavaScript. You might still be able to use some of the features but some of the useful features use JavaScript. Thank you!

TRITE: Topical Research Interests Comparator

J

Q

U

Y

Second appearance of the title indicates that the topic was run the second time with some of the words as must include and a different eliminated words list was used.
: ABO blood group system / ABO blood group system; Acatalasia, acatalassaemia; Acetylcholine (ACh); Actin; Action of chemical carcinogens / Action of chemical carcinogens; Affective disorders; Alzheimer's disease / Alzheimer's disease; Antibodies / Antibodies; Antibody effector functions / Antibody effector functions; Antibody engineering; Apoptosis

: Bithorax complex (BX-C)

: Cell signalling; Central dogma; Centromere / Centromere; Chemical carcinogens and carcinogenesis / Chemical carcinogens and carcinogenesis; Constant and variable regions / Constant and variable regions; CpG islands

: DiGeorge syndrome; Diabetes mellitus; The DMD gene and its protein product dystrophin; DNA manipulation enzymes; DNA methylation; DNA methylation and transcription; Down's syndrome (trisomy 21)

: Ehlers-Danlos syndrome (EDS); The elucidation of antibody structure; Endocytosis; Epstein-Barr virus (EBV)

: Fluorescence energy transfer; Fragile X syndrome

: G protein-coupled receptors; Genome organization; Gibberellin (GA); Growth factor(s)

: Haemoglobin(s); Helix-loop-helix

: IL-2; Idiotypes / Idiotypes; Immunoglobulin (antibody) isotypes; Immunoglobulin genes; Imprinting; Interleukins

: Kanamycin; Klinefelter syndrome

: L-DOPA; Leucine zipper

: Macrophage; Merogone; Metastasis; Mismatch repair; Muscular dystrophy; Mutagenicity and carcinogenesis / Mutagenicity and carcinogenesis

: Neuroblastoma

: Okazaki fragment; Olfactory signal transduction; Oncogenesis

: Parkinson's disease; Parvoviridae; Plasma lipoproteins and their receptors; Polymerase chain reaction; Post-translational modification of proteins; Prenatal diagnosis; Programmed cell death; Protein degradation and turnover; Protein engineering; Protein folding; Protein kinase(s); Protein phosphatases; Proto-oncogene; Pseudomonas; Purinergic systems

: RETROVIRUSES; Receptor-mediated endocytosis; Reichert's membrane; Repetitive DNA; Retinoblastoma

: Sendai virus; Somatic cell hybrids; Synchrotron radiation (SR)

: T cell; T cell activation; T cell receptor(s); TATA box; Telomere / Telomere; Thalassaemia; Thrombin; Tobacco mosaic virus (TMV); Transcription; Transcription factors; Transfer ribonucleic acid (tRNA); Transformer (tra) gene; Transgenic technologies; Translocation; Transmembrane domain (TM); Transposable genetic elements; Tumour necrosis factor (TNF, cachectin, lymphotoxin, LT)

: Vertebrate neural development; Voltage-gated ion channels; von Hippel-Lindau disease

: WAGR syndrome; Wilms' tumour; WRCE Administrative Core; WRCE Alphavirus Vaccines for Biodefense; WRCE Arenavirus Pathogenic Modulation of Host Cell Signaling; WRCE Bacillus anthracis Host Interactions; WRCE BSL-4 Core; WRCE Cell Wall Proteins in Bacillus anthracis as Vaccines; WRCE Chimeric Alphaviruses for Serological VEEV Diagnostics; WRCE Computational Biology Core; WRCE Control Elements of Nipah Virus Define Antiviral Targets; WRCE Correlates of Immunity Elicited by Live Yersinia pestis Vaccine; WRCE Development and Evaluation of Human Brucellosis; WRCE Development of a Small Animal Model for Monkeypox; WRCE Discovery of Subunit Vaccines for Smallpox; WRCE Francisella tularensis Live Attenuated Vaccines; WRCE Inhibitors of Yersinia pestis Virulence as Anti-plague Agents; WRCE Morphelino Antisense Oligos as Therapy for RNA Virus-Induced Disease; WRCE Multi-track Drug Discovery Program to Combat Arboviruses; WRCE Mutational Analysis of RVFV and Vaccine Virulence; WRCE New Diagnostic Methods for Acute Rickettsial Infections; WRCE Non-Human Primate Aerobiology Core; WRCE Non-Human Primate Core; WRCE Novel Genetic Tools for Viral Biodefense; WRCE Overall; WRCE Pathogenesis Expression Core; WRCE Poxvirus Host Range Genes and Their Role in Pathogenesis; WRCE Proteomics Core; WRCE Rapid Diagnostic Tools for Q fever; WRCE RCE Biodefense Seminar Series; WRCE Rickettsial Vaccine Development by Microarray Analysis; WRCE RVFV Molecular Genetics and Virus-cell Interactions; WRCE Shock in Hamster Models of Hantavirus Infection; WRCE Small Animal Core; WRCE Small Molecule Screening Laboratory; WRCE Thioaptamer-guided Targeting of Ribosome Assembly in B. anthracis; WRCE Transition Metal-mediated SPOS for Biodefense Discovery; WRCE Vaccine Development of Rift Valley Fever Virus

: X-chromosome inactivation; X-ray crystallography; Xeroderma pigmentosum (XP)

: Zygotic gene

Last modified: Friday, 02-Jul-2004 19:22:43 CDT